Avacta Therapeutics (AIM: AVCT) has reported clinical proof of mechanism for AVA6103, its next-generation pre|CISION® peptide-drug conjugate, from the ongoing Phase 1 FOCUS-01 trial.
Avacta Therapeutics (AIM: AVCT) has reported clinical proof of mechanism for AVA6103, its next-generation pre|CISION® peptide-drug conjugate, from the ongoing Phase 1 FOCUS-01 trial.
Avacta Therapeutics (AIM: AVCT) has appointed experienced biotechnology finance executive Mats Blom to its Board of Directors, where he will also serve as Chair of the Audit Committee.
Avacta Therapeutics (AIM: AVCT) has settled an accelerated deferred convertible bond repayment of £2.613 million in cash, reducing the remaining principal under the facility to £12 million.
Avacta (AIM: AVCT) has granted a substantial package of share options to its management team, including 13.4 million options to chief executive Christina Coughlin, as part of an incentive and
Amaroq Ltd (LON, NASDAQ Iceland: AMRQ, OTCQX: AMRQF) has reported approximately 9,000 ounces of gold production for the first half of 2026, putting output above the midpoint of its H1 guidance
Amaroq Ltd. (LON: AMRQ) has commenced its 2026 resource drilling programme at the Nanoq gold project in South Greenland, targeting a potential maiden Mineral Resource Estimate later this year.
Amaroq Ltd (LSE and NASDAQ Iceland: AMRQ, OTCQX: AMRQF) has commenced a focused scout diamond drilling programme at its Minturn iron-copper-gold prospect in Northwest Greenland, providing the first direct test
Amaroq Ltd (AIM, NASDAQ Iceland: AMRQ, OTCQX: AMRQF) has moved its London listing from AIM to the Main Market of the London Stock Exchange, marking a significant step in the
European gas prices hit a four-month high on Monday as escalating tensions between the US and Iran fuelled fears of a supply crunch this winter.
Amaroq Minerals has reported further high-grade underground drilling results from its Nalunaq Gold Mine in southern Greenland.
European buyers imported a record volume of liquefied natural gas from Russia’s Yamal export hub during the first half of 2026, generating around €6 billion in revenue for Moscow.
Alkemy Capital Investments Plc (LON: ALK) has announced that its wholly owned subsidiary, Tees Valley Lithium Ltd, has entered into non-binding Heads of Terms with Canadian lithium developer E3 Lithium